These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2005-002355-40 An open randomized phase III trial of six cycles of docetaxel versus surveillance after radical prostatectomy in prostate cancer patients with high grade pT3 or margin positive pT2 not-yet-due
Ongoing 2006-001657-94 A randomised adjuvant Phase III Trial of six cycles of docetaxel and hormonal treatment versus hormonal treatment in patients with intermediate or high-risk prostate cancer treated with radical radiot... not-yet-due
Ongoing 2008-003138-33 A Randomized, Open Label, Phase III, Multicenter, 2-Arm Study of Androgen deprivation +/- Taxotere´âĺ (Docetaxel) for Non metastatic Prostate Cancer Patients with a Rising PSA. not-yet-due
Ongoing 2011-003078-10 SPCG 16 Sensi-cab Randomized phase III trial comparing cabazitaxel in combination with hormone therapy to hormone therapy alone in metastatic prostate cancer not-yet-due